Communication Compounding Pharmaceutical Companies 
pharmaphorum
MARCH 19, 2021
The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this.
Pharmafile
JANUARY 20, 2023
Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. The compound, known as nitrosamines or NTTP, often emerges from chemical reactions that can take place throughout the manufacturing process.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 3, 2021
Using content metrics, companies can understand how their current content is received and engaged with, which will, in turn, helps clarify the most effective and efficient ways to connect and communicate with their audience in the future, resulting in increased speed to market and effective content engagement.
pharmaphorum
JUNE 23, 2021
Just as the wider healthcare system continues to acclimate to a new normal, the way pharma and physicians communicate is experiencing a technological revolution. Physician access issues coupled with message delivery disconnects only compounded the problem. Inefficient communications pre-COVID.
Viseven
AUGUST 15, 2024
In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? Additionally, the COVID-19 pandemic has intensified public scrutiny of pharmaceutical companies, creating a unique opportunity to build trust with patients.
ISPE
MARCH 16, 2023
By removing the need for manual handling and reducing the risk of contamination, pharmaceutical manufacturers can produce products that meet the highest standards of quality. Automated systems offer a range of options for pharmaceutical companies. ISPE Good Practice Guide on Containment for Potent Compounds 4.
pharmaphorum
JANUARY 10, 2023
Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues.
Expert insights. Personalized for you.
141 
Let's personalize your content